News & Articles

Pharmaceutical News and Articles

Comprehensive and up-to-date drug news for both consumers and healthcare professionals.

Including medical news, pharmaceutical industry news, new drug approvals, applications and clinical trial results.

Daily MedNews

-- Here are the latest clinical trials, courtesy of ClinicalConnection.com: Schizophrenia This study will evaluate an investigational medication for schizophrenia. Participants must be diagnosed with schizophrenia and be aged 18 to 65. The research...
Here are some of the latest health and medical news developments, compiled by the editors of HealthDay: Cattle Vaccines May Reduce E. coli Outbreaks in Humans Vaccinating cattle against E. coli bacteria could significantly improve the safety of beef...
FRIDAY, Dec. 4 -- Timing of surgical repair or reconstruction of multiple-ligament knee injuries may not affect patient outcome, a new study has found. Multiple-ligament knee injuries result from traumatic knee dislocations that can occur in...
FRIDAY, Dec. 4 -- Increased exercise, reduced soda consumption and self-weighing are among the most effective weight control strategies for adolescents, a new study shows. Researchers surveyed 130 adolescents about their weight-control strategies...
FRIDAY, Dec. 4 -- The makers of 24 different prescription painkillers on Friday presented federal regulators with plans to curb the abuse of these opioid drugs. The pharmaceutical companies have been under pressure from U.S. Food and Drug...

More...

Pharma Industry News

From Associated Press (December 4, 2009) WASHINGTON--Pharmaceutical executives are laying out plans to prevent the misuse of prescription painkillers, under pressure from regulators trying to prevent hundreds of fatal overdoses...
- New report recommends banning gifts and free meals and mandating disclosure of financial ties between doctors and drug companies Trenton, NJ, Dec. 3, 2009 - Attorney General Anne Milgram today released a report from the Division of Consumer...
From Associated Press (December 4, 2009) LONDON--Pharmaceutical company AstraZeneca PLC said Friday it has won U.S. approval for use of its schizophrenia drug Seroquel XR as an add-on treament for major depressive disorder. But the London-based...
From Associated Press (December 4, 2009) LONDON--The European Medicines Agency warns that young children given GlaxoSmithKline’s swine flu shot may get a fever after their second dose. In a statement issued Friday, the European drug regulator...
From Associated Press (December 3, 2009) WASHINGTON--A consumer advocacy group is petitioning the government to ban the weight loss pill Meridia because a recent study suggests it increases risk of heart attack, stroke and death. A letter...

More...

New Drug Approvals

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Dec 1, 2009 - Dyax Corp. announced today that the U.S. Food and Drug Administration (FDA) has granted approval for Kalbitor (ecallantide) for the treatment of acute attacks of hereditary angioedema (HAE) in...
PRINCETON, N.J., Dec. 2 /PRNewswire-FirstCall/ -- Novo Nordisk said today that the U.S. Food and Drug Administration (FDA) has approved a 10 mcg dose formulation of Vagifem (estradiol vaginal tablets) for the treatment of atrophic vaginitis due...
WHITEHOUSE STATION, N.J.--Merck & Co. and Santarus Inc. said Tuesday the Food and Drug Administration approved Merck’s over-the-counter version of the Santarus prescription heartburn drug Zegerid. San Diego-based Santarus had partnered with...
BRIDGEWATER, N.J., Nov. 25 /PRNewswire/ -- The FDA granted traditional approval for Intelence (etravirine) tablets, a non-nucleoside reverse transcriptase inhibitor (NNRTI). Intelence is the only NNRTI specifically indicated for use...
INDIANAPOLIS, Nov 30, 2009 /PRNewswire-FirstCall via COMTEX News Network/ -- The U.S. Food and Drug Administration (FDA) has approved Cymbalta (duloxetine HCl) for the maintenance treatment of generalized anxiety disorder (GAD) in adults, Eli...

More...

New Drug Applications

CHADDS FORD, Pa., Dec. 3 /PRNewswire-FirstCall/ -- Endo Pharmaceuticals today announced that it received a complete response letter from the U.S. Food and Drug Administration (FDA) regarding the New Drug Application (NDA) for...
JERUSALEM--(BUSINESS WIRE)--Dec 1, 2009 - Teva Pharmaceutical Industries Ltd. (NASDAQ: TEVA), today announced the submission of a Biologics License Application (BLA) with the U.S. Food and Drug Administration (FDA) for XM02, a granulocyte...
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Dec 2, 2009 - Javelin Pharmaceuticals, Inc., a leading developer and marketer of specialty pharmaceutical products for pain management, today announced that it has submitted a New Drug Application (NDA) to the...
DARMSTADT, Germany, November 30, 2009 – Merck KGaA announced today that its US affiliate received a refuse to file letter from the US Food and Drug Administration (FDA) on the New Drug Application (NDA) for Cladribine Tablets, Merck...
ROCKVILLE, Md.--(BUSINESS WIRE)--Nov 25, 2009 - Human Genome Sciences, Inc. (Nasdaq: HGSI) today announced that it has submitted a Biologics License Application (BLA) to the U.S. Food and Drug Administration (FDA) for Zalbin (albinterferon...

More...

Clinical Trials

Results Demonstrate Positive Proof of Mechanism SAN DIEGO, Dec. 3 /PRNewswire/ -- Amira Pharmaceuticals, Inc. announced today initial positive data from a Phase 1 clinical study of AM461, the Company's second oral selective antagonist of the...
- SPC3649 Successfully Inhibits miR-122, a microRNA Important for Hepatitis C Viral Replication, Thereby Significantly Reducing Hepatitis C Virus in the Bloodstream in Chimpanzees Chronically Infected With the Hepatitis C Virus   - SPC3649...
Investigators Presented Results at the Society of Urologic Oncology Annual Meeting BETHESDA, Md., Dec. 4 /PRNewswire/ -- Drs. Neal Shore and E. David Crawford presented results for prostate-specific antigen (PSA) recurrence from the additional...
New Data Shows PharmAthene's Lyophilized rPA Anthrax Vaccine Could Provide a Stable Cold-Chain-Free Vaccine for Potential Storage and Distribution at Room Temperature ANNAPOLIS, Md., Dec. 4 /PRNewswire-FirstCall/ -- PharmAthene, Inc. (NYSE Amex:...
Review of clinical trials of oral insulin published this month in Diabetes, Obesity and Metabolism WORCESTER, MA, December 3, 2009 (GlobeNewswire) – Published in the journal Diabetes, Obesity and Metabolism, an independent review of clinical...

More...

More News Resources


MedNotes
Advertisement

(web2)